Mass-spectrometric identification of a novel angiotensin peptide in human plasma.
about
Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular PathophysiologyCellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its ComorbiditiesThe compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challengesIdentification of a potent endothelium-derived angiogenic factorThe application of Gaussian mixture models for signal quantification in MALDI-TOF mass spectrometry of peptidesPeptidomics of prolyl endopeptidase in the central nervous system.Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides.Network modeling reveals steps in angiotensin peptide processing.Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.What is new in uremic toxicity?The "artificial artery" as in vitro perfusion modelA peptidomics strategy to elucidate the proteolytic pathways that inactivate peptide hormones.Role of non-classical renin-angiotensin system axis in renal fibrosis.A system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy.Investigating endogenous peptides and peptidases using peptidomicsAlamandine reduces leptin expression through the c-Src/p38 MAP kinase pathway in adipose tissueDetection of metals and metalloproteins in the plasma of stroke patients by mass spectrometry methodsBiochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?Hypertension and microvascular remodelling.Angiotensin-converting enzyme 2 in the brain: properties and future directions.New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.Endothelial metabolism of angiotensin II to angiotensin III, not angiotensin (1-7), augments the vasorelaxation response in adrenal cortical arteries.The renin-angiotensin system and diabetes: an update.The proteoglycan syndecan 4 regulates transient receptor potential canonical 6 channels via RhoA/Rho-associated protein kinase signaling.Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways.Blood pressure and renal hemodynamic effects of angiotensin fragments.The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease.Is the renin-angiotensin system actually hypertensive?New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis.Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.Use of Biomarkers in the Evaluation and Treatment of Hypertensive Patients.Human Antimicrobial Peptides in Bodily Fluids: Current Knowledge and Therapeutic Perspectives in the Postantibiotic Era.The enzymatic activity of the VEGFR2 receptor for the biosynthesis of dinucleoside polyphosphates.The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?Absolute quantification of endogenous angiotensin II levels in human plasma using ESI-LC-MS/MS.Antiplasmodial activity study of angiotensin II via Ala scan analogs.Cardiovascular effects of angiotensin A: a novel peptide of the renin-angiotensin system.
P2860
Q26742054-37041813-FFEC-435F-965C-DC2DC32C86FAQ26798487-A0FC6C9D-444C-40F5-9147-53CA0B70BF2AQ26823573-733252FB-C94F-4E73-A0F7-616D0C6A4532Q28534947-A97C4D99-1F78-4453-BEFE-7DE05F95FE44Q28544751-A0D9391B-1E0D-4EE1-8AA2-116C19598FFEQ30884523-8E6C86C3-2C20-40B2-A416-DA0C84F5F547Q34268925-C85D4C24-23E6-4878-AD37-8469D2E7C83CQ34530891-BE1EB6EF-F1FE-4B2D-AB6E-07F043081C50Q34543485-0725F642-F789-486F-A89C-7084E00D4059Q34589157-2FAA1F20-9497-4AFA-BDEF-F428E03FFC8FQ34625487-42406F3E-7107-4ABD-8A57-83571DD75595Q34795373-88B42286-273A-46DB-9689-2C5955F2625DQ35506543-AD4D1D41-9D98-4D4F-8F95-53C50308861BQ36112117-B2359DD7-1462-4AB2-B19D-3479B0D892E0Q36163374-69D2A39A-AEAD-44D8-A5D1-8FA50873F39FQ36395019-797BCFD1-B669-42F8-84BB-62BA1D45C631Q36539409-DA9DF086-EA16-41E7-83CB-FD11ADD3C773Q36699651-AE31AA6D-8D6D-4600-8A93-84EA97B6CC75Q37077130-19841253-D9E8-4AA7-99CD-98B39D66E3ECQ37155907-6E275E3B-9C2F-4FF8-BC4B-7884C0DF780FQ37293326-1501B10E-DDDE-4319-B0AF-51D53C9E8D0AQ37331077-5EA5AC6F-93F3-4786-98AA-93200B6CA2E4Q37344441-AEFBD58D-49E1-45C2-B26B-B4E065AF323BQ37436623-85DF6540-0401-438D-8934-630C43BC8F4EQ37454928-2FDDA5EE-6EB4-4F03-AFB3-01A96F6B11E3Q37853834-46981864-2916-4279-A5B6-1465668AA3EDQ37938867-0B17AFA8-3661-46F3-B2F0-0C32AD8F00C4Q38112330-695A8673-8BEA-45B3-AB7F-1BCBE7A25A01Q38206729-637AE450-417D-4354-AF5A-097F7042CD58Q38217456-F6A4B8A1-52E5-47D3-B77E-A96F8C73AC45Q38317550-27C2AA1B-5FEB-4E02-AA94-45E7A1298077Q38750210-DE15EFE2-07FC-4855-8D1C-3B5EEAAA8E1CQ38843567-434A694E-6CEA-494D-B4A1-646787927CF7Q39091774-EE4D24B6-6FCD-4B99-8F3C-21DDD86329B8Q39157601-42610563-39DA-439A-8C25-E79CA7D9E972Q39376362-88B059DA-0BC0-420A-9906-FDE070F22520Q39416346-01284AE0-A524-426B-BDCC-32689313E4B1Q41995755-6575B152-2BBF-450B-A2AD-C5820F0D1954Q43034707-494AD387-E205-4630-AD9E-5ACAE992C3EFQ44077837-914D2501-A6FA-4C20-B97B-EDB26A820BA9
P2860
Mass-spectrometric identification of a novel angiotensin peptide in human plasma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Mass-spectrometric identification of a novel angiotensin peptide in human plasma.
@ast
Mass-spectrometric identification of a novel angiotensin peptide in human plasma.
@en
type
label
Mass-spectrometric identification of a novel angiotensin peptide in human plasma.
@ast
Mass-spectrometric identification of a novel angiotensin peptide in human plasma.
@en
prefLabel
Mass-spectrometric identification of a novel angiotensin peptide in human plasma.
@ast
Mass-spectrometric identification of a novel angiotensin peptide in human plasma.
@en
P2093
P50
P1476
Mass-spectrometric identification of a novel angiotensin peptide in human plasma
@en
P2093
Alexander Oksche
Annette Wiedon
Eberhard Krause
Hartmut Schlüter
Jens Furkert
Joachim Jankowski
Johan Gobom
Markus Tölle
Michael Beyermann
Mirjam Schuchardt
P304
P356
10.1161/01.ATV.0000253889.09765.5F
P407
P577
2006-11-30T00:00:00Z